ZUZASSY Trademark
Trademark Overview
On Thursday, October 30, 2025, a trademark application was filed for ZUZASSY with the United States Patent and Trademark Office. The USPTO has given the ZUZASSY trademark a serial number of 99470371. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, May 26, 2026. This trademark is owned by Pfizer Inc.. The ZUZASSY trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, respiratory, and viral diseases and disorders; Pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, hormonal disorders, skin disorders, arthritis, cancer, cachexia, hypertension, migraine, pain, stroke, obesity and diabetes; Pharmaceuticals, namely, anti-infectives; Smoking cessation preparations; Vaccines for human use
General Information
| Serial Number | 99470371 |
| Word Mark | ZUZASSY |
| Filing Date | Thursday, October 30, 2025 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, May 26, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, May 26, 2026 |
Trademark Statements
| Goods and Services | Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, respiratory, and viral diseases and disorders; Pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, hormonal disorders, skin disorders, arthritis, cancer, cachexia, hypertension, migraine, pain, stroke, obesity and diabetes; Pharmaceuticals, namely, anti-infectives; Smoking cessation preparations; Vaccines for human use |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, October 30, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Pfizer Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10001-2192
US |
| Party Name | Pfizer Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10001-2192
US |
Trademark Events
| Event Date | Event Description |
| Thursday, October 30, 2025 | NEW APPLICATION ENTERED |
| Thursday, October 30, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, October 30, 2025 | APPLICATION FILING RECEIPT MAILED |
| Thursday, February 5, 2026 | ASSIGNED TO EXAMINER |
| Thursday, February 5, 2026 | NON-FINAL ACTION WRITTEN |
| Thursday, February 5, 2026 | NON-FINAL ACTION E-MAILED |
| Thursday, February 5, 2026 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, April 27, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, April 27, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, April 27, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, April 28, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, May 20, 2026 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, May 26, 2026 | PUBLISHED FOR OPPOSITION |
| Tuesday, May 26, 2026 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
